NOTCH1 and central nervous system cancer: Furthermore, mechanistic exploration revealed that T+A@Glu‐NPs degraded the BRD4 protein, leading to the downregulation of Notch1 gene transcription and the inhibition of the Notch1 signaling pathway, thereby augmenting the therapeutic efficacy of glioma chemotherapy.